Cell Bound Complement Activation Products Are Associated with Disease Activity in Systemic Lupus Erythematosus

被引:0
|
作者
Kalunian, Kenneth C. [1 ]
Chatham, W. Winn [2 ]
Massarotti, Elena M. [3 ]
Reyes-Thomas, Joyce [4 ]
Furie, Richard [5 ]
Buyon, Jill [6 ]
Somers, Emily C. [7 ]
Putterman, Chaim [4 ]
Gross, Rachel L. [8 ]
Kirou, Kyriakos A. [9 ]
Ramsey-Goldman, Rosalind [10 ]
Hsieh, Christine [11 ]
Dervieux, Thierry [12 ]
Weinstein, A. [13 ]
机构
[1] UCSD Sch Med, La Jolla, CA USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] N Shore LIJ Hlth Syst, Lake Success, NY USA
[6] NYU, Sch Med, New York, NY USA
[7] Univ Michigan, Ann Arbor, MI 48109 USA
[8] Albert Einstein Coll Med, New York, NY USA
[9] Hosp Special Surg, New York, NY 10021 USA
[10] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[11] Univ Chicago, Chicago, IL 60637 USA
[12] Exagen Diagnost, Albuquerque, NM USA
[13] Washington Hosp Ctr, Washington, DC 20010 USA
来源
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
603
引用
收藏
页码:S261 / S262
页数:2
相关论文
共 50 条
  • [41] Cell-bound complement activation products associate with lupus severity in SLE
    Arriens, Cristina
    Alexander, Roberta Vezza
    Narain, Sonali
    Saxena, Amit
    Collins, Christopher E.
    Wallace, Daniel J.
    Massarotti, Elena
    Conklin, John
    Kalunian, Kenneth C.
    Putterman, Chaim
    Ramsey-Goldman, Rosalind
    Buyon, Jill P.
    Askanase, Anca
    Furie, Richard A.
    James, Judith A.
    Bello, Ghalib A.
    Manzi, Susan
    Ahearn, Joseph
    O'Malley, Tyler
    Weinstein, Arthur
    Dervieux, Thierry
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [42] PCSK9 IS ASSOCIATED WITH DISEASE ACTIVITY AND IMPLICATED IN IMMUNE ACTIVATION IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Liu, A.
    Rahman, M.
    Hafstrom, I.
    Ajeganova, S.
    Frostegard, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1361 - 1362
  • [43] Increased IgG on Cell-Derived Plasma Microparticles in Systemic Lupus Erythematosus Is Associated With Autoantibodies and Complement Activation
    Nielsen, Christoffer T.
    Ostergaard, Ole
    Stener, Line
    Iversen, Line V.
    Truedsson, Lennart
    Gullstrand, Birgitta
    Jacobsen, Soren
    Heegaard, Niels H. H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1227 - 1236
  • [44] Complement and systemic lupus erythematosus
    Mark J Walport
    Arthritis Research & Therapy, 4
  • [45] Complement and systemic lupus erythematosus
    Karp, DR
    CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (05) : 538 - 542
  • [46] Complement and systemic lupus erythematosus
    Walport, Mark J.
    ARTHRITIS RESEARCH & THERAPY, 2002, 4 (Suppl 3) : S279 - S293
  • [47] Complement activation in patients with systemic lupus erythematosus without nephritis
    Mollnes, TE
    Haga, HJ
    Brun, JG
    Nielsen, EW
    Sjöholm, A
    Sturfeldt, G
    Mårtensson, U
    Bergh, K
    Rekvig, OP
    RHEUMATOLOGY, 1999, 38 (10) : 933 - 940
  • [48] COMPLEMENT ACTIVATION AND VASCULAR INJURY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ABRAMSON, S
    BELMONT, HM
    HOPKINS, P
    BUYON, J
    WINCHESTER, R
    WEISSMANN, G
    JOURNAL OF RHEUMATOLOGY, 1987, 14 : 43 - 46
  • [49] Antiendothelial cell antibodies and systemic lupus erythematosus disease activity
    Resplandy, F
    Dupuy, R
    Seigneur, M
    Constans, J
    Conri, C
    Boisseau, MR
    20TH EUROPEAN CONFERENCE ON MICROCIRCULATION, 1998, : 395 - 397
  • [50] Exploring complement activation to develop biomarkers for systemic lupus, erythematosus
    Tsokos, GC
    ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3404 - 3407